1 / 16

Methods developed for SELEX 1

Methods developed for SELEX 1. Presented by: chang chu Guided by: Prof. Liu Prof. Jiang. 1. Subash Chandra Bose Gopinath, Anal Bioanal Chem (2007) 387:171–182. 1. Introduction Basic processes Features 2. Methods 3. Aptamer base.

sheperd
Download Presentation

Methods developed for SELEX 1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Methods developed for SELEX1 Presented by: chang chu Guided by: Prof. Liu Prof. Jiang 1. Subash Chandra Bose Gopinath, Anal Bioanal Chem (2007) 387:171–182

  2. 1. Introduction Basic processes Features 2. Methods 3. Aptamer base

  3. 1. SELEX(systematic evolution of ligands by exponential enrichment) is a process that involves the progressive purification from a combinatorial library of nucleic acid ligands with a high affinity for a particular target by repeated rounds of partitioning and amplification. Three Processes Selection of ligand sequences that bind to a target partitioning ofaptamers from non-aptamers via affinity methods amplification of bound aptamers

  4. Antibody VS aptamer in therapeutic use1 Advantages of antibodies • Pharmacokinetic and other systemic properties of antibodies are often sufficient to support product development • Comparatively long circulating half-lives • Not susceptible to nuclease degradation • Antibody technologies are widely distributed Limitations of antibodies • Antibodies are produced biologically in a process • Viral or bacterial contamination • Large size limits Advantages of aptamers • Aptamers are produced chemically in a readily scalable process • Chemical production process is not prone to viral or bacterial contamination • Non-immunogenic • Smaller size allows more efficient entry into biological compartments • Limitations of aptamers • Pharmacokinetic and other systemic properties are variable and often hard to predict • Shorter half-life • Unmodified aptamers are highly susceptible to serum degradation 1. Anthony D. Keefe, Supriya Pai and Andrew Ellington(2010). Aptamers as therapeutics. Nature

  5. 2. Methods • Nitrocellulose membrane filtration • Using affinity surfaces • Using affinity tags • Using column matrices or ligands • Cross-linking • Antibody-based • Using gel electrophoresis • Surface plasmon resonance • Flow cytometry • Capillary electrophoresis • Automated selection

  6. Initial rounds of selection: long incubation times & less stringent conditions • Later cycles: stringent conditions, such as changing the buffer conditions, reaction volume and time of incubation. • Monovalent & divalent cations • Pre-negative selection

  7. Using affinity surfaces • Affinity surfaces: allow proteins and small molecules to bind with them & have affinities with RNA or DNA. • Magnetic beads, affinity titer plates • RNA Aptamer against Panama influenza virus subtype A2 2. Kumar PKR, Gopinath SCB, Misono T, Kawasaki K (2004) Japanese patent JP2004-293679

  8. STEP4 selection STEP5 Amplification Step 1 STEP2 Negative selection Step 3 Counter selection • The unbound molecules were again collected and incubated with beads coated with the target A/Panama virus • After this incubation, the beads were washed three times with 300 μl of binding buffer. • Bound RNAs were recovered with a hot 7M urea solution. • Bound molecules were precipitated by ethanol. • Reverse transcription • PCR • In vitro transcription • Coating the whole virus onto beads • BSA Blocking • Washing the coated beads. • Denaturing the pool RNA(90 °C for 2 min and allowed to cool at roomtemperature for 10 min) • The unbound RNA was collected with the help of magnet and applied onto beads coated with the same subtype A/Aichi virus as the counter-selection to remove molecules specific to A/Aichi. • Incubating for 10 min. • Incubating the pool RNA with the BSA-coated beads in binding buffer for 10 min.

  9. Flow cytometry • Detecting the fluorescence Leu3a-FITC RNA aptamer-FITC

  10. Using gel electrophoresis 0.7% native agarose gel

  11. Using gel electrophoresis Electrophoresis through 4 %, polyacrylamide, TBE, 0.05 % SDS, and then recovered from the gel by the crush-and-soak method. Smith D, Kirschenheuter GP, Charlton J, Guidot DM, Repine JE(1995) Chem Biol 2:741–750

  12. Using capillary electrophoresis • The nucleic acid sequences that bind the target undergo a mobility shift, migrating at a different rate, allowing them to be separated from the inactive sequences. 4 Thus, there is no need to wash the active sequences off a column as in conventional SELEX, eliminating any kinetic bias. • Higher speed, better resolution capacity, minimal sample dilution, fewer cycles. 4.Mendonsa SD, Bowser MT (2004) Anal Chem 76:5387–5392

  13. a poly (vinyl alcohol)-coated capillary 40.2 cm long and with an inner diameter of 50 μm • The sample was applied to the capillary at 5 psi for 5 s and monitored under UV detection at 254 nm • After the nonspecific species had migrated out, the CE fractions containing specific DNA sequences were collected • PCR • Anti-IgE aptamers with dissociation constants as low as 27 nM were obtained in only two rounds of selection.

  14. 5. Jose Cruz-Toledo1,*,y, Maureen McKeague2,*,y, Xueru Zhang2, Amanda Giamberardino2, Erin McConnell2, Tariq Francis2, Maria C. DeRosa2,3,* and Michel Dumontier1,3,4,* Database, Vol. 2012, Article ID bas006, doi:10.1093/database/bas006

More Related